Healthcare, Industrials, Financials Sep 09, 2021 05:53 PM (GMT+8)
Cailian news agency, September 9, baolaite announced that on September 8, 2021, the company received the second round of audit inquiry letter on Guangdong baolaite Medical Technology Co., Ltd. applying for issuing shares to specific objects (audit letter  No. 020240) issued by Shenzhen Stock Exchange. The listing audit center of Shenzhen Stock Exchange reviewed the application documents submitted by the company for issuing shares to specific objects, and formed audit questions. In accordance with the requirements of the audit inquiry letter, the company will work with relevant intermediaries to implement the audit inquiry questions one by one, timely reply to the audit inquiry letter by means of temporary announcement, and submit relevant documents through the listing audit business system of Shenzhen Stock Exchange.
This text is a result of machine translation.